© Copyright by HealthHelpZone.com. All rights reserved.
BRENTWOOD, Tenn., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2023 results before the market opens on Tuesday, November 7, 2023, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live... ❯❯❯
MARKHAM, Ontario, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the third quarter of 2023 after market close on Thursday, November 9, 2023. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Friday,... ❯❯❯
Tuesday, October 10 is World Mental Health DayTORONTO, Oct. 04, 2023 (GLOBE NEWSWIRE) -- “When Hope Breaks Through”, the newly released film, from award winning director Matthew Wagner, is already receiving a lot of buzz and Ontario Shores Centre for Mental Health Sciences and Ontario Shores Foundation are thrilled to be offering an exclusive viewing including a Q and A with the star of the film, Mike Shoreman Tuesday October 10,... ❯❯❯
The Recent Acquisition of a Majority Stake in a Manufacturer of Antibacterial and Antiviral Fabrics Expected to Create Synergies for New Products BEIJING, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that it plans to increase its research and development of new high-tech applications of silk... ❯❯❯
MARKHAM, Ontario, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2023 third quarter results after market close on Thursday, November 9, 2023. Nitin Jain, President and Chief Executive Officer, and David Hung, Chief Financial Officer and Executive Vice President, will host a conference call for the investment community the following day, Friday,... ❯❯❯
Program provides healthcare providers access to Diagnamed’s novel brain health AI platformTORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative artificial intelligence healthcare company, announced today the launch of CERVAI™ Healthcare Provider Network, a partnership program to expand access to the Company’s brain health AI platform for healthcare... ❯❯❯
NORCROSS, Ga., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3, today reported the positive outcome of its fourth data and safety monitoring board (DSMB) meeting for NAVIGATE, its seamless, adaptive, Phase 2b/3 study of belapectin in patients with portal hypertension caused by non-alcoholic steatohepatitis (NASH) liver cirrhosis. NAVIGATE is... ❯❯❯
PRESS RELEASE: REGULATED INFORMATION 3 October 2023, 7:00 CEST Disclosure of transparency notification Mechelen, Belgium, 3 October 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today, in accordance with Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on the... ❯❯❯
The Friese Family Tower advances the hospital’s 50-year legacy of care in the San Fernando Valley and expands world-class care close to homeTARZANA, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Providence Cedars-Sinai Tarzana Medical Center has opened its new patient tower, the centerpiece of an extensive and ongoing hospital expansion and modernization plan. Named for the Donald Friese family in recognition of their $50... ❯❯❯
Allarity will present on development of several drug-specific DRP® companion diagnostics, and participate in a panel discussion with speakers from Merck and Roche BOSTON, October 2, 2023 — Allarity Therapeutics, Inc. (Allarity or the Company) (Nasdaq: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, is pleased to... ❯❯❯